On Monday, Boston Scientific Corp (NYSE: BSX) opened lower -3.77% from the last session, before settling in for the closing price of $97.52. Price fluctuations for BSX have ranged from $85.98 to $109.50 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -17.84% over the past five years. Company’s average yearly earnings per share was noted 20.95% at the time writing. With a float of $1.48 billion, this company’s outstanding shares have now reached $1.48 billion.
Boston Scientific Corp (BSX) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Boston Scientific Corp is 0.39%, while institutional ownership is 93.40%. The most recent insider transaction that took place on Dec 01 ’25, was worth 1,758,189. In this transaction EVP& Grp Pres, MedSurg & APAC of this company sold 17,313 shares at a rate of $101.55, taking the stock ownership to the 23,600 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Officer proposed sale 17,313 for $101.55, making the entire transaction worth $1,758,188.
Boston Scientific Corp (BSX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.7 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.66) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.79 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.16% during the next five years compared to -17.84% drop over the previous five years of trading.
Boston Scientific Corp (NYSE: BSX) Trading Performance Indicators
Check out the current performance indicators for Boston Scientific Corp (BSX). In the past quarter, the stock posted a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.19. Likewise, its price to free cash flow for the trailing twelve months is 36.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.87, a number that is poised to hit 0.78 in the next quarter and is forecasted to reach 3.47 in one year’s time.
Technical Analysis of Boston Scientific Corp (BSX)
Boston Scientific Corp (NYSE: BSX) saw its 5-day average volume 10.02 million, a positive change from its year-to-date volume of 8.09 million. As of the previous 9 days, the stock’s Stochastic %D was 21.48%.
During the past 100 days, Boston Scientific Corp’s (BSX) raw stochastic average was set at 16.75%, which indicates a significant increase from 12.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.24 in the past 14 days, which was higher than the 2.06 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $99.13, while its 200-day Moving Average is $101.38. Nevertheless, the first resistance level for the watch stands at $96.36 in the near term. At $98.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $100.71. If the price goes on to break the first support level at $92.02, it is likely to go to the next support level at $90.20. Assuming the price breaks the second support level, the third support level stands at $87.67.
Boston Scientific Corp (NYSE: BSX) Key Stats
There are currently 1,482,442K shares outstanding in the company with a market cap of 139.11 billion. Presently, the company’s annual sales total 16,747 M according to its annual income of 1,854 M. Last quarter, the company’s sales amounted to 5,065 M and its income totaled 755,000 K.
